Necrotic Enteritis in Poultry: Clostridium perfringens Infection, Diagnosis, and Prevention

What is Necrotic Enteritis

Necrotic enteritis (NE) is a significant enteric disease of commercial poultry, primarily broiler chickens and turkeys, caused by the Gram-positive, anaerobic, spore-forming bacterium Clostridium perfringens [1, 2, 3]. The disease is characterized by acute or subclinical forms that result in substantial economic losses estimated at USD 6 billion annually to the global poultry industry [1, 4]. NE presents as a multifactorial condition where C. perfringens type G strains, possessing the NetB toxin gene, proliferate in the small intestine following predisposing factors such as coccidial infection and dietary changes [1, 5, 4]. The clinical form manifests as sudden mortality with characteristic intestinal lesions, while the subclinical form results in reduced feed intake, impaired weight gain, and elevated feed conversion ratios without overt mortality [1, 2].

Etiology

Clostridium perfringens is a ubiquitous bacterium found in soil, dust, sewage, and the gastrointestinal tract of healthy animals [6, 7]. The species is classified into toxinotypes based on the production of major toxins (alpha, beta, epsilon, iota) and the newly recognized NetB toxin [5, 4]. Strains associated with NE in poultry are predominantly classified as type G, defined by the presence of the netB gene encoding the NetB pore-forming toxin [8, 4]. The pathogenesis of NE requires the concurrent presence of predisposing factors that allow C. perfringens to proliferate to high numbers (10^7 to 10^9 CFU/g of intestinal content) and produce toxins [1, 5]. Key virulence factors include the NetB toxin, which is a beta-pore-forming toxin essential for disease induction, and the alpha-toxin (CPA), which has historically been considered central but is now recognized as a secondary factor [8, 5, 4]. Additional virulence-associated factors include a sortase-dependent pilus encoded by the fimA and fimB genes, which mediates collagen binding and adherence to damaged intestinal epithelium [9]. Other factors include hyaluronidases, sialidases, and the collagen adhesin Cna, which facilitate tissue colonization and degradation [9, 4].

Epidemiology

NE is a disease of intensively managed broiler flocks, with highest incidence in birds aged 2 to 6 weeks [2, 10]. The disease is more prevalent in flocks raised on diets containing high levels of animal protein, fish meal, or wheat, which provide substrates for C. perfringens proliferation [2, 11]. The ban on in-feed antibiotic growth promoters in many regions, including the European Union, Canada, and Hong Kong, has led to a resurgence of NE [12, 1, 13]. The disease is often associated with concurrent coccidial infection, particularly Eimeria maxima, which causes mucosal damage and provides the necessary environment for C. perfringens colonization [14, 11, 15]. Genomic analyses have identified a hypervirulent, globally distributed clone of C. perfringens type G that has persisted over a 20-year period (1993 to 2013) and harbors an increased number of virulence genes [4]. Environmental reservoirs include farm animal feeds, which can carry NetB-positive strains [4].

Clinical Signs

The clinical presentation of NE is divided into acute and subclinical forms [1, 2]. The acute form is characterized by sudden onset of depression, inappetence, diarrhea (often with blood or mucus), and ruffled feathers, followed by rapid mortality within 24 to 48 hours [2, 10]. Morbidity can reach 10 to 40 percent in affected flocks, with mortality typically ranging from 2 to 10 percent but occasionally exceeding 50 percent [2, 10]. The subclinical form presents with no overt mortality but is associated with reduced feed intake, poor weight gain, and increased feed conversion ratio [1, 2]. Birds may exhibit mild intestinal inflammation and reduced nutrient absorption, leading to economic losses through decreased performance [1, 11].

Pathology

Gross pathological findings are confined to the small intestine, particularly the jejunum and ileum [2, 10]. The intestinal wall is distended, friable, and covered with a pseudomembrane composed of necrotic debris, fibrin, and bacterial cells [2, 10]. The mucosa is congested and hemorrhagic, with multifocal to coalescing areas of necrosis [2, 10]. Microscopic examination reveals severe villus atrophy, sloughing of the epithelium, and massive infiltration of heterophils and mononuclear cells into the lamina propria [2, 10]. The presence of large numbers of Gram-positive rods in the necrotic debris is characteristic [6]. The subclinical form shows less severe lesions, including mild villus blunting and increased crypt depth [11, 16].

Diagnosis

Diagnosis of NE is based on a combination of clinical signs, gross pathology, histopathology, and microbiological or molecular detection of C. perfringens and its toxins [17, 2, 18]. The gold standard for diagnosis is the demonstration of characteristic intestinal lesions at necropsy, combined with the isolation of C. perfringens from intestinal contents in high numbers (greater than 10^7 CFU/g) [2, 6]. Histopathology reveals the presence of Gram-positive rods adherent to the necrotic mucosa [6]. Molecular detection of the netB gene by polymerase chain reaction (PCR) is the definitive method for confirming the involvement of type G strains [4, 18]. Multiplex PCR assays targeting the major toxin genes (cpa, cpb, etc, iA, netB) are used for toxinotyping [4, 18]. Fecal detection of C. perfringens alpha-toxin has been developed using a protein A agglutination kit, which can detect the toxin at concentrations as low as 12 ng/mL with high specificity against Escherichia coli and Salmonella enteritidis [17]. Fecal acute-phase proteins, including calprotectin (MRP-126) and C-reactive protein (CRP), have been identified as noninvasive biomarkers for NE, with MRP-126 showing a 320-fold increase from healthy to NE-affected birds [19].

Diagnostic Workflow

flowchart TD
    A[Clinical suspicion of NE], > B[Necropsy and gross examination]
    B, > C{Intestinal lesions present?}
    C, >|Yes| D[Collect intestinal contents and tissue]
    C, >|No| E[Consider subclinical NE]
    D, > F[Microbiological culture on anaerobic media]
    D, > G[Histopathology with Gram stain]
    F, > H[Quantitative culture >10^7 CFU/g]
    G, > I[Gram-positive rods in necrotic debris]
    H, > J[PCR for netB and toxin genes]
    I, > J
    J, > K[Confirm type G strain]
    K, > L[Diagnosis confirmed]
    E, > M[Fecal biomarker testing]
    M, > N[Elevated MRP-126 or CRP]
    N, > O[Subclinical NE diagnosis]

Differential Diagnosis

NE must be differentiated from other enteric diseases of poultry, including coccidiosis (caused by Eimeria spp.), ulcerative enteritis (caused by Clostridium colinum), and salmonellosis [2, 20]. Coccidiosis presents with bloody diarrhea and oocysts in feces, while ulcerative enteritis is characterized by discrete ulcers in the ceca and liver [2, 20]. Salmonellosis may cause diarrhea but lacks the characteristic pseudomembrane and Gram-positive rods [2]. Other non-Clostridium perfringens agents, including Escherichia coli and Salmonella spp., can produce necrotic enteritis-like lesions but are typically associated with different clinical presentations [20].

Treatment

Therapeutic intervention for NE is primarily directed at controlling C. perfringens proliferation and reducing the predisposing factors [2, 13]. Antimicrobial agents, including penicillin, amoxicillin, and tetracyclines, have been used historically, but their use is increasingly restricted due to antimicrobial resistance concerns and regulatory bans [12, 21, 13]. Genomic studies have identified high prevalence of tetracycline resistance genes (tet) and the emergence of macrolide resistance (erm(T)) in C. perfringens isolates [21]. Alternative treatments include bacteriophage therapy, which uses lytic phages (e.g., CPD4 and CPD7) to specifically target and lyse C. perfringens without affecting the broader microbiota [22, 23]. Phage cocktails designed with cross-resistance guidance have shown efficacy in reducing intestinal lesions and C. perfringens colonization [22]. Probiotics, particularly Lactobacillus spp., are used to competitively exclude C. perfringens from the intestinal niche, enhance beneficial microbiota, and modulate the immune response by reducing inflammatory cytokines [12, 16]. Postbiotics derived from Lactobacillus reuteri have been shown to improve villus height, reduce intestinal permeability, and downregulate pro-inflammatory cytokines (IL-1beta, IFN-gamma) [16]. Synbiotics (combinations of probiotics and prebiotics) have demonstrated efficacy in reducing lesion scores and improving growth performance [11, 24]. Plant extracts, including tannins and essential oils, exhibit antimicrobial activity against C. perfringens and coccidia, and can improve intestinal barrier function [25, 15]. Usnic acid and tannic acid have been shown to induce apoptosis in coccidian sporozoites and inhibit C. perfringens growth [15].

Prevention

Prevention of NE relies on a multifaceted approach combining management, nutrition, biosecurity, and vaccination [2, 13, 26]. Management strategies include reducing dietary protein levels, avoiding high-risk feed ingredients (e.g., fish meal, wheat), and maintaining optimal litter moisture and ventilation [2, 11]. Biosecurity protocols, including thorough cleaning and disinfection of houses between flocks, are critical to reduce environmental C. perfringens loads [2]. Vaccination is a promising strategy for NE control, with several vaccine candidates under development [27, 8, 26]. The only commercially available vaccines are based on the CPA and NetB toxins, but they provide only partial protection [8]. Novel vaccine antigens include the pilus proteins (FimA, FimB), the collagen adhesin CnaA, and the zinc metalloprotease ZMP [8]. Bivalent vaccines targeting both NE and avian colibacillosis have been developed using oil-adjuvanted formulations [28]. In ovo vaccination (injection into the amnion on embryonic day 18) has been explored as a delivery route for postbiotics and vaccines [29]. Genetic selection for resistance to NE is an emerging area, with specific MHC-B haplotypes (e.g., B21) associated with improved resistance to coccidiosis and NE [30]. Probiotic and postbiotic supplementation, including Lactobacillus spp., has been shown to reduce intestinal lesions, improve feed conversion, and decrease mortality in NE-challenged flocks [12, 16]. Bacteriophage therapy, using cocktails of phages with complementary host ranges, provides a targeted, non-antibiotic intervention that can be administered via drinking water [22, 23].

Control

Control of NE in commercial poultry operations requires an integrated approach that addresses the multifactorial nature of the disease [2, 13]. Key control points include the management of coccidial infection through vaccination or anticoccidial drugs, as coccidiosis is a primary predisposing factor [14, 11]. Dietary modifications, such as the use of low-protein diets or the inclusion of feed additives (e.g., organic acids, enzymes), can reduce the substrate available for C. perfringens [2, 13]. The use of natural adsorbents, including biochar and clay minerals, has been proposed to bind NetB toxin and reduce intestinal inflammation, though direct evidence for NetB-specific adsorption is lacking [31]. The implementation of strict biosecurity measures, including all-in/all-out production systems and effective disinfection, is essential to break the cycle of infection [2]. Surveillance for NE should include regular monitoring of intestinal lesion scores, fecal C. perfringens counts, and the use of noninvasive biomarkers (MRP-126, CRP) to detect subclinical disease [19]. The development of standardized challenge models for evaluating vaccine and therapeutic efficacy is critical, as many experimental models fail to replicate the aggressive conditions of field outbreaks [14].

References

[1] Emami, N., Dalloul, R. Centennial Review: Recent developments in host-pathogen interactions during necrotic enteritis in poultry. Poultry Science, 2021.

[2] Tsiouris, V. Poultry management: a useful tool for the control of necrotic enteritis in poultry. Avian Pathology, 2016.

[3] Piva, A. Necrotic enteritis in poultry. Journal, 2015.

[4] Kiu, R., Brown, J., Bedwell, H., et al. Genomic analysis on broiler-associated Clostridium perfringens strains and exploratory caecal microbiome investigation reveals key factors linked to poultry necrotic enteritis. Animal Microbiome, 2019.

[5] Flores-Díaz, M., Barquero-Calvo, E., Ramírez, M., et al. Role of Clostridium perfringens Toxins in Necrotic Enteritis in Poultry. Journal, 2016.

[6] Shelke, P., Pawade, M., Mhase, P., et al. Antibiotic Sensitivity and Histopathological Study of Clostridium perfringens Associated with Necrotic Enteritis in Poultry. International Journal of Current Microbiology and Applied Sciences, 2018.

[7] Johansson, A. Clostridium perfringens the causal agent of necrotic enteritis in poultry. Journal, 2006.

[8] Waller, S., Galvão, C. C., Rodrigues, R. R., et al. Clostridium perfringens Antigens and Challenges for Development of Vaccines against Necrotic Enteritis in Poultry. Anaerobe, 2024.

[9] Lepp, D., Zhou, Y., Ojha, S., et al. Clostridium perfringens Produces an Adhesive Pilus Required for the Pathogenesis of Necrotic Enteritis in Poultry. Journal of Bacteriology, 2021.

[10] Natalia, L. Clostridial Necrotic Enteritis in Poultry. Journal, 2004.

[11] Shah, B., Al Hakeem, W. G., Shanmugasundaram, R., et al. A comparative evaluation of antibiotic and synbiotic supplementation on production performance and necrotic enteritis severity in broilers during an experimental necrotic enteritis challenge. Frontiers in Physiology, 2025.

[12] Razzaq, S., Hina, Q., Muneeb, M., et al. A Narrative Review on The Beneficial Effects of Lactobacillus Probiotics Against Necrotic Enteritis in Poultry. Bio Communications, 2025.

[13] Mahmood, K., Rahman, S., Hussain, I., et al. Non-antibiotic strategies for the control of necrotic enteritis in poultry. Journal, 2014.

[14] Dias, G. S., Chagas, K. P. F., Carvalho Silva, A., et al. Experimental induction of subclinical necrotic enteritis in poultry - a review. Revista Agraria Academica, 2026.

[15] Xu, H., Yang, M., Fu, J., et al. Usnic acid and tannic acid as inhibitors of coccidia and Clostridium perfringens: alleviating necrotic enteritis and improving intestinal health in broiler chickens. Journal of Animal Science and Biotechnology, 2025.

[16] Wu, M., Zha, Y., Xiong, Y., et al. Lactobacillus reuteri postbiotics improved growth performance and intestinal health of broilers with necrotic enteritis. BMC Veterinary Research, 2025.

[17] Kurnia, R., Nugroho, C. M. H., Silaen, O. S. M., et al. Development of Rapid Detection Kit for Necrotic Enteritis Disease in Poultry using Protein A Agglutination. World's Veterinary Journal, 2024.

[18] Kumar, N. P. MOLECULAR DETECTION AND CHARACTERIZATION OF CLOSTRIDIUM PERFRINGENS TOXIN GENES RESPONSIBLE FOR NECROTIC ENTERITIS IN POULTRY OF ANDHRA PRADESH. Journal, 2008.

[19] Mahmoud, M., Buiatte, V., Baumrucker, C., et al. Investigating Acute-Phase Proteins in Feces of Broiler Chickens Undergoing Necrotic Enteritis: A Potential Tool for Assessment and Monitoring. Avian diseases, 2025. *** Disclaimer: This article is for educational and informational purposes only. It is not intended to substitute for professional veterinary advice, diagnosis, treatment, or regulatory guidance. Always consult a licensed veterinarian or qualified specialist regarding animal health, disease diagnosis, and therapeutic decisions.

[20] Uzal, F., Senties-cue, C. G., Rimoldi, G., et al. Non-Clostridium perfringens infectious agents producing necrotic enteritis-like lesions in poultry. Avian Pathology, 2016.

[21] García-Vela, S., Martínez-Sancho, A., Ben Said, L., et al. Pathogenicity and Antibiotic Resistance Diversity in Clostridium perfringens Isolates from Poultry Affected by Necrotic Enteritis in Canada. Pathogens, 2023.

[22] Ahn, E., Kim, J., Tobin, I., et al. Cross-resistance-guided phage cocktail design for effective mitigation of necrotic enteritis in poultry. Microbiology Research, 2026.

[23] Muneeb, M., Khan, E. U., Saima, et al. Effects of bacteriophage supplementation on performance, gut health and blood biochemistry in broilers challenged with necrotic enteritis. Research in Veterinary Science, 2025.

[24] Acharya, A., Devkota, B., Basnet, H. B., et al. Effects of different levels of synbiotic administration on growth performance and response to post-hatch necrotic enteritis in Cobb-500 broilers. Discover Life, 2024.

[25] Carrasco, J. D., Redondo, L., Redondo, E., et al. Use of Plant Extracts as an Effective Manner to Control Clostridium perfringens Induced Necrotic Enteritis in Poultry. BioMed Research International, 2016.

[26] Shamshirgaran, M. A., Golchin, M. Necrotic enteritis in chickens: a comprehensive review of vaccine advancements over the last two decades. Avian Pathology, 2024.

[27] Gaucher, M.-L. Unravelling Necrotic Enteritis in Poultry: The Quest for an Effective Vaccine. Scientia, 2025.

[28] Indrawati, A., Safika, S., Nugroho, C., et al. Development and Evaluation of a Bivalent Oil-Adjuvanted Vaccine Against Necrotic Enteritis and Avian Colibacillosis in Poultry. Advances in Animal and Veterinary Sciences, 2025.

[29] Dong, B., Çalık, A., Dalloul, R. Impact of in ovo and water supplementation of a postbiotic on intestinal integrity and immune responses in broiler chickens challenged with necrotic enteritis. Frontiers in Veterinary Science, 2025.

[30] Niraula, A., Dalloul, R. Genetic basis of disease resistance to coccidiosis and necrotic enteritis in chickens. Poultry Science, 2025.

[31] Agada, S. E., Oladokun, S. Natural Adsorbents as Therapeutic Candidates Against Necrotic Enteritis in Poultry: A Conceptual Review. Agriculture, 2026.

[32] Potential effects of herbal tea extracts as an alternative to antimicrobials to control the necrotic enteritis in poultry. Asian Journal of Agriculture and Biology, 2025.

[33] Rahmi, V. A., Indrawati, A., Poetri, O., et al. Evaluation of a Novel Protein A (Staphylococcus aureus)–IgG Matrix Complex as an Adjuvant for a Poultry Necrotic Enteritis Toxoid Vaccine. Advances in Animal and Veterinary Sciences, 2025.

[34] Kochish, I., Myasnikova, O., Polonuchkina, T. Phytobiotic using with necrotic enteritis in “Ross–308” cross parent flock. Poultry and Chicken Products, 2025.

[35] Kim, D. M., Liu, J., Whitmore, M. A., et al. Two intestinal microbiota-derived metabolites, deoxycholic acid and butyrate, synergize to enhance host defense peptide synthesis and alleviate necrotic enteritis. Journal of Animal Science and Biotechnology, 2024.